Proactive Investors - Run By Investors For Investors

Curetis expects near term decision by FDA approving first product in US

CEO Oliver Schacht from Curetis (EN Amsterdam:CURE) tells Proactive Investors their Unyvero Platform finds killer bugs in hospitals and tells doctors which antibiotics to use.

Schacht says they expect the FDA to approve the platform and first product in the U.S. which is a test for life-threatening ammonia. Schacht says he anticipates this to happen in the next few weeks.

Meet ICOx Innovations at our event, New York , 30 January 2019. Register here »
View full PROAC profile View Profile

Proactiveinvestors Timeline

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use